We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Genmab Expands use of IDBS’ ActivityBase Xtended Edition in Hybridoma Discovery

News   Sep 12, 2007

 
Genmab Expands use of IDBS’ ActivityBase Xtended Edition in Hybridoma Discovery
 
 
 

RELATED ARTICLES

The Power of Collaboration: Tackling Pharmaceutical Challenges

News

In this article, we explore how pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help overcome some of the challenges the industry is facing.

READ MORE

Targeting a Protease To Treat Inflammatory Bowel Disease

News

The protease MT1-MMP could be a possible future target for drugs to treat inflammatory bowel disease (IBD) according to a new study.

READ MORE

A Nice Reactive Ring to It

News

Researchers have introduced a new synthetic process for producing an important family of carbon-based molecules known as γ-aryl-β-ketoesters. These molecules are used in the production of many vital pharmaceuticals.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE